Abstract
Mounting evidence points to dietary habits as an important determinant of health/disease prevention. Although the linkages with diet are intriguing, the literature is also laden with many inconsistencies. The reasons for these inconsistencies are likely multi-factorial, but probably reflect variation in the ability of bioactive constituents to reach or to influence a specific and critical molecular target(s). Knowledge about three types of biomarkers will assist in comparing the effectiveness of foods and drugs: (1) exposure (amount and time needed to bring about a response), (2) effect (amounts and activity of specific molecular target[s]) and (3) susceptibility determinants (agent-gene interactions or diet-drug interactions). As the era of molecular nutrition unfolds, a greater understanding of how foods and their components influence normal cellular process and ultimately health will surely arise. Knowledge about the molecular targets for bioactive food components may also help explain individuality in response to drugs. Such information will be critical in the development of effective tailored strategies for optimizing health.
Keywords: Dietary, drugs, foods, genes, health, nutrigenomics, targets, omega-3, prebiotic, probiotic
Current Pediatric Reviews
Title:Common Molecular Targets for Bioactive Food Components and Drugs
Volume: 8 Issue: 3
Author(s): John A. Milner
Affiliation:
Keywords: Dietary, drugs, foods, genes, health, nutrigenomics, targets, omega-3, prebiotic, probiotic
Abstract: Mounting evidence points to dietary habits as an important determinant of health/disease prevention. Although the linkages with diet are intriguing, the literature is also laden with many inconsistencies. The reasons for these inconsistencies are likely multi-factorial, but probably reflect variation in the ability of bioactive constituents to reach or to influence a specific and critical molecular target(s). Knowledge about three types of biomarkers will assist in comparing the effectiveness of foods and drugs: (1) exposure (amount and time needed to bring about a response), (2) effect (amounts and activity of specific molecular target[s]) and (3) susceptibility determinants (agent-gene interactions or diet-drug interactions). As the era of molecular nutrition unfolds, a greater understanding of how foods and their components influence normal cellular process and ultimately health will surely arise. Knowledge about the molecular targets for bioactive food components may also help explain individuality in response to drugs. Such information will be critical in the development of effective tailored strategies for optimizing health.
Export Options
About this article
Cite this article as:
A. Milner John, Common Molecular Targets for Bioactive Food Components and Drugs, Current Pediatric Reviews 2012; 8 (3) . https://dx.doi.org/10.2174/157339612802139424
DOI https://dx.doi.org/10.2174/157339612802139424 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Common Pathways in Health Benefit Properties of RSV in Cardiovascular Diseases, Cancers and Degenerative Pathologies
Current Pharmaceutical Biotechnology Moderate Hyperhomocysteinemia and Immune Activation
Current Pharmaceutical Biotechnology Proinflammatory Cytokines and Sickness Behavior in Rheumatic Diseases
Current Pharmaceutical Design A Historical and Clinical Perspective Endorsing Person-centered Management of Fibromyalgia Syndrome
Current Rheumatology Reviews Structure and Expression of Different Serum Amyloid A (SAA) Variants and their Concentration-Dependent Functions During Host Insults
Current Medicinal Chemistry TNF alpha Inhibition as Treatment Modality for Certain Rheumatologic and Gastrointestinal Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Herbal Medicines for Diabetes Management and its Secondary Complications
Current Diabetes Reviews Update on Intravenous Immunoglobulins (IVIg) Mechanisms of Action and Off- Label use in Autoimmune Diseases
Current Pharmaceutical Design Iontophoresis: Drug Delivery System by Applying an Electrical Potential Across the Skin
Drug Delivery Letters Rheumatological Manifestations in Diabetes Mellitus
Current Diabetes Reviews Mitral Stenosis in Pregnancy: A Comprehensive Review of a Challenging Cardio-Obstetric Clinical Entity
Reviews on Recent Clinical Trials Nanocarriers Assisted siRNA Gene Therapy for the Management of Cardiovascular Disorders
Current Pharmaceutical Design <i>Arctium Lappa</i> and Management of Liver Functions to Detoxify the Bloodstream
The Natural Products Journal Folate Nutrigenetics: A Convergence of Dietary Folate Metabolism, Folic Acid Supplementation, and Folate Antagonist Pharmacogenetics
Drug Metabolism Letters How to Advise Aspirin Use in Patients Who Need NSAIDs
Current Pharmaceutical Design <i>Uncaria tomentosa</i> (Willd. ex Schult.): Focus on Nutraceutical Aspects
Current Bioactive Compounds Hydroxychloroquine Sulfate (Plaquenil): A Possible Candidate for Pandemic SARS-CoV-2 or (COVID-19) ?
Coronaviruses Mechanisms of Inflammatory Atherosclerosis in Rheumatoid Arthritis
Current Immunology Reviews (Discontinued) Pharmacokinetics/Pharmacodynamics Model-Supported Early Drug Development
Current Pharmaceutical Biotechnology Viscosupplementation with Intra-Articular Hyaluronic Acid for Treatment of Osteoarthritis in the Elderly
Current Pharmaceutical Design